Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants
This study is not yet open for participant recruitment.
Verified January 2013 by University of Manitoba
Sponsor:
University of Manitoba
Information provided by (Responsible Party):
University of Manitoba
ClinicalTrials.gov Identifier:
NCT01630538
First received: June 25, 2012
Last updated: April 4, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | May 2015 |
| Estimated Primary Completion Date: | October 2014 (Final data collection date for primary outcome measure) |